Detalhe da pesquisa
1.
A Prognostic Survival Model Incorporating Patient-Reported Outcomes for Transplant-Ineligible Patients With Multiple Myeloma.
Oncologist
; 2024 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38636951
2.
Important questions for the malignant hematologist to consider when designing or evaluating a study with patient-reported outcome measures (PROMs).
Eur J Haematol
; 109(1): 3-9, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35403753
3.
Exploring the components of bleeding outcomes in transfusion trials for patients with hematologic malignancy.
Transfusion
; 61(1): 286-293, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33047878
4.
Maintenance therapy in transplant ineligible adults with newly-diagnosed multiple myeloma: A systematic review and meta-analysis.
Eur J Haematol
; 105(5): 626-634, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32710492
5.
Managing antithrombotic therapy in immune thrombocytopenia: development of the TH2 risk assessment score.
Blood
; 132(25): 2684-2686, 2018 12 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-30409773
6.
Testosterone use causing erythrocytosis.
CMAJ
; 189(41): E1286-E1288, 2017 10 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-29038321
7.
Trajectory of Symptoms in Patients Undergoing Autologous Stem Cell Transplant for Multiple Myeloma: A Population-Based Cohort Study of Patient-Reported Outcomes.
Clin Lymphoma Myeloma Leuk
; 21(9): e714-e721, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34099429
8.
External validation of the FIRST trial's simplified frailty score in a population-based cohort.
Leukemia
; 35(6): 1823-1827, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33839738
9.
Thrombovascular events affect quality of life in patients with systemic lupus erythematosus.
J Rheumatol
; 38(6): 1017-9, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21362766